Original Source(s)
Related Content
FDA approves dostarlimab for advanced rectal cancer
The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.
by Mouj Hijazi
October 19, 2026
-
3 min
FDA raises TMB threshold for pembrolizumab
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
-
3 min
AI may aid segmental pulmonary embolism detection
Incidental pulmonary embolism detection increased following AI deployment on routine contrast-enhanced CT, with the clearest increase occurring in segmental emboli.
October 27, 2026
-
4 min